Prophylactic systemic low-dose pirfenidone attenuates intrauterine adhesion by inhibiting the TGF-β1/Smad3 pathway
{{output}}
Background: Intrauterine adhesion (IUA) is a severe fibrotic disorder lacking effective non-surgical treatments. This study explored pirfenidone (PFD), an antifibrotic drug approved for treating lung fibrosis, as a potential ther... ...
